Filing Details
- Accession Number:
- 0000950170-24-116783
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-10-23 19:49:49
- Reporting Period:
- 2024-10-21
- Accepted Time:
- 2024-10-23 19:49:49
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1750149 | Inhibikase Therapeutics Inc. | IKT | Biological Products, (No Disgnostic Substances) (2836) | 263407249 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1986806 | Arvind Kush | 3350 Riverwood Parkway Se, Suite 1900 Atlanta GA 30339 | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2024-10-21 | 145,000 | $1.37 | 145,000 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Acquisiton | 2024-10-21 | 60,000 | $0.00 | 60,000 | $2.22 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 60,000 | 2034-10-21 | No | 4 | A | Direct |
Footnotes
- The option shares vest 50% on each of the first two anniversaries of October 21, 2024.
Billionaire Hedge Funds
